Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LYMPHOSPIR : Impact of Surgery in Addition to Optimal Management of Lymphedema.

NCT03776214 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03776214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03776214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LYMPHOSPIR : Impact of Surgery in Addition to Optimal Management of Lymphedema.
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
April 1, 2018
Completion date
December 31, 2019
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

optimal treatment of lymphedema